Literature DB >> 16479198

Successful use of recombinant factor VIII devoid of von Willebrand factor during multiple teeth extractions in a patient with type 3 von Willebrand disease.

Yoshihiko Sakurai1, Midori Shima, Yuichirou Imai, Shoko Omura, Tadaaki Kirita, Akira Yoshioka.   

Abstract

We report a 55-year-old patient with type 3 von Willebrand disease who underwent multiple tooth extractions with successful hemostatic management using recombinant factor VIII. The patient was previously misdiagnosed and treated incorrectly then at 53 years old, he was diagnosed with type 3 von Willebrand disease. As he had avoided dental treatments for two decades due to severe bleeding after dental extraction, multiple severe caries and marginal periodontitis were revealed. The patient refused the use of blood products in hemostatic management because he was afraid of blood-borne diseases and development of anti-von Willebrand factor alloantibodies. After close consultation, we therefore decided to use recombinant factor VIII. Four teeth extraction procedures were executed twice. Before extraction, bolus recombinant factor VIII (50 IU/kg) was administered intravenously followed by continuous infusion (5-10 IU/kg per h) for approximately 48 h. The factor VIII:C level increased from about 1 to 20-32% 30 min after bolus infusion. During continuous infusion (10 IU/kg/h), factor VIII:C was maintained at more than 10%. Little bleeding occurred during and after the multiple teeth extractions and during suture removal. On frequent examinations during a 1-year follow-up, neither von Willebrand factor nor factor VIII inhibitors were detected.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16479198     DOI: 10.1097/01.mbc.0000214711.19116.09

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  3 in total

1.  Factor VIII-mediated global hemostasis in the absence of von Willebrand factor.

Authors:  Masahiro Takeyama; Shogo Kasuda; Yoshihiko Sakurai; Midori Shima; Tomohiro Takeda; Shoko Omura; Hiroyuki Naka; Akira Yoshioka
Journal:  Int J Hematol       Date:  2007-06       Impact factor: 2.490

Review 2.  The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology.

Authors:  Mike A Laffan; Will Lester; James S O'Donnell; Andrew Will; Robert Campbell Tait; Anne Goodeve; Carolyn M Millar; David M Keeling
Journal:  Br J Haematol       Date:  2014-08-12       Impact factor: 6.998

3.  Dental invasive procedures in von Willebrand disease outpatients treated with high purity FVIII/VWF complex concentrate (Fanhdi®): experience of a single center.

Authors:  Valeria De Padua; Umberto Romeo; Cristina Santoro; Riccardo Bosco; Erminia Baldacci; Antonietta Ferretti; Francesco Malaspina; Maria Gabriella Mazzucconi; Domenico Gaglioti
Journal:  Heliyon       Date:  2020-02-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.